May 6 |
Voyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns
|
May 6 |
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
|
May 3 |
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
|
May 2 |
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
|
Apr 22 |
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
|
Apr 16 |
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
|
Apr 9 |
Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
|